A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples